Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Microdosimetry and radiocurability: modelling targeted therapy with beta-emitters

A E Nahum1

  • 1Joint Department of Physics, Institute of Cancer Research, Sutton, Surrey, UK.

Physics in Medicine and Biology
|October 1, 1996
PubMed
Summary

Tumour control probability (TCP) modeling shows that beta-emitter targeted therapy is less effective for small tumors due to dose fall-off. Micrometastases may be difficult to eliminate with this method alone.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Prostate Dose-painting Radiotherapy and Radiobiological Guided Optimisation Enhances the Therapeutic Ratio.

Clinical oncology (Royal College of Radiologists (Great Britain))·2015
Same author

Mechanistic modelling of radiotherapy-induced lung toxicity.

The British journal of radiology·2012
Same author

Radiobiologically guided optimisation of the prescription dose and fractionation scheme in radiotherapy using BioSuite.

The British journal of radiology·2012
Same author

An NTCP Analysis of Urethral Complications from Low Doserate Mono- and Bi-Radionuclide Brachytherapy.

Prostate cancer·2011
Same author

Escalation and intensification of radiotherapy for stage III non-small cell lung cancer: opportunities for treatment improvement.

Clinical oncology (Royal College of Radiologists (Great Britain))·2009
Same author

Addendum to the IPEMB code of practice for the determination of absorbed dose for x-rays below 300 kV generating potential (0.035 mm Al-4 mm Cu HVL).

Physics in medicine and biology·2005

Area of Science:

  • Medical Physics
  • Radiation Oncology
  • Nuclear Medicine

Background:

  • Tumour control probability (TCP) is crucial for radiation therapy efficacy.
  • Beta-emitters are used in targeted radionuclide therapy.
  • Understanding dose distribution in heterogeneous targets is essential.

Purpose of the Study:

  • To model tumour control probability (TCP) for spherical tumours of varying radii using different beta-emitters.
  • To investigate the impact of electron disequilibrium and volume-dose distribution on TCP.
  • To compare the efficacy of beta-emitter targeted therapy with external-beam therapy for small tumours.

Main Methods:

  • Computed dose at varying radii using numerical integration of point-dose kernels.
  • Converted dose distributions into volume-dose (V(D)) and cell survival (n(D)) curves.

Related Experiment Videos

  • Calculated TCP for different cumulated activities, tumour radii, and radiosensitivities.
  • Compared TCP with external-beam therapy for a fixed number of tumour cells.

    • Main Results:

    • Electron disequilibrium significantly affects dose distribution, especially at small radii and sphere edges.
    • Using volume-dose distribution (V(D)) instead of mean dose decreases TCP for both large and small tumours.
    • Iso-TCP curves show a minimum at a tumour radius near the maximum beta-particle range.
    • Eliminating micrometastases solely with beta-emitters is improbable due to dose fall-off at small radii.

    Conclusions:

    • Beta-emitter targeted therapy faces limitations in eradicating small tumours and micrometastases.
    • Dose fall-off effects at small tumour radii reduce the effectiveness of beta-emitters.
    • Alternative strategies are needed to overcome these limitations in targeted radionuclide therapy.